What is Medifast 12-1 Month Momentum %?
12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2024-05-30), Medifast's 12-1 Month Momentum % is -56.75%.
The industry rank for Medifast's 12-1 Month Momentum % or its related term are showing as below:
MED's 12-1 Month Momentum % is ranked worse than
91.18% of 102 companies
in the Personal Services industry
Industry Median: -2.84 vs MED: -56.75
Competitive Comparison of Medifast's 12-1 Month Momentum %
For the Personal Services subindustry, Medifast's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medifast's 12-1 Month Momentum % Distribution in the Personal Services Industry
For the Personal Services industry and Consumer Cyclical sector, Medifast's 12-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where Medifast's 12-1 Month Momentum % falls into.
Medifast(NYSE:MED) 12-1 Month Momentum % Calculation
12-1 Month Momentum % is calculated as following:
| 12-1 Month Momentum % | = | ( Price 1-month ago | / | Price 12-month ago | - 1 ) | * | 100 % |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medifast(NYSE:MED) 12-1 Month Momentum % Explanation
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
Medifast 12-1 Month Momentum % Related Terms
Thank you for viewing the detailed overview of Medifast's 12-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.
Medifast (Medifast) Business Description
Industry
GURUFOCUS.COM »STOCK LIST »Consumer Cyclical » Personal Services » Medifast Inc (NYSE:MED) » Definitions » 12-1 Month Momentum %
Comparable Companies
WW CSV MUGH YYGH EJH RGS EVTK TRNR IVP PDRO ROL SCI HRB BFAM TSX:BYD FTDR MCW HKSE:01448 LSE:CVSG OHEL:MUSTI
Traded in Other Exchanges
MED:Mexico MDF:Germany MDF:Germany
Address
100 International Drive, Baltimore, MD, USA, 21202
Website
Medifast Inc is a United states based company that produces, distributes and sells products concerning weight loss, weight management, and healthy living. The company generates its revenue from point of sale transactions executed over an e-commerce platform for weight loss, weight management, and other consumable health and nutritional products.
Executives
| Jeffrey J Brown | director | 19900 MACARTHUR BLVD, SUITE 570, IRVINE CA 92612 |
| Andrea B Thomas | director | C/O MEDIFAST, INC., 100 INTERNATIONAL DRIVE, BALTIMORE MD 21202 |
| Michael A. ho*r | director | MEDIFAST, INC., 100 INTERNATIONAL DRIVE, 18TH FLOOR, BALTIMORE MD 21202 |
| Scott Schlackman | director | 3600 CRONDALL LANE, OWINGS MILLS MD 21117 |
| Hallquist Constance J. | director | 3600 CRONDALL LANE, OWINGS MILLS MD 21117 |
| Elizabeth A. Geary | director | C/O MEDIFAST, INC., 100 INTERNATIONAL DRIVE, BALTIMORE MD 21202 |
| Daniel R Chard | director, officer: Chief Executive Officer | NU SKIN ENTERPRISES, INC., 75 WEST CENTER STREET, PROVO UT 84601 |
| Jonathan Barrett Mackenzie | officer: VP, Finance & CAO | 100 INTERNATIONAL DRIVE, BALTIMORE MD 21202 |
| Kevin G Byrnes | director | C/O MEDIFAST, INC., 3600 CRONDALL LANE, OWINGS MILLS MD 21117 |
| Michael C Macdonald | director | C/O MEDIFAST, INC., 3600 CRONDALL LANE, OWINGS MILLS MD 21117 |
| James P. Maloney | officer: Chief Financial Officer | 415 HOLIDAY DRIVE, PITTSBURGH PA 15220 |
| Ming Xian | director | MEDIFAST, INC., 100 INTERNATIONAL DRIVE, 18TH FLOOR, BALTIMORE MD 21202 |
| Carl E Sassano | director | C/O MEDIFAST, INC., 3600 CRONDALL LANE, OWINGS MILLS MD 21117 |
| Joseph P Kelleman | officer: (Interim) CFO | 3600 CRONDALL LANE, OWINGS MILLS MD 21117 |
| Timothy G Robinson | officer: Chief Financial Officer | C/O MEDIFAST, INC., 3600 CRONDALL LANE, OWINGS MILLS MD 21117 |
Medifast (Medifast) Headlines
From GuruFocus
Medifast, Inc. Announces Quarterly Dividend
By PRNewswire PRNewswire • 07-06-2022
Medifast Announces First Quarter 2023 Financial Results
By PRNewswire PRNewswire • 05-01-2023
Medifast to Announce Financial Results for the Third Quarter Ended September 30, 2023
By Business Wire • 10-23-2023
Medifast Inc (MED) Reports Q3 2023 Earnings: Revenue Down 39.6%, Net Income at $23.1 Million
By GuruFocus Research • 11-06-2023
Medifast Inc (MED): A Deep Dive into its Dividend Performance
By GuruFocus Research • 09-18-2023
Health is Top Priority for Majority of U.S. Adults Despite Continuous Cycle of Failed Diets
By PRNewswire PRNewswire • 07-11-2022
Medifast Appoints Steven Zenker as Vice President of Investor Relations
By PRNewswire PRNewswire • 03-02-2023
Medifast's OPTAVIA Program Named #1 Weight Loss Program in the U.S. by Revenue for 2021*
By PRNewswire PRNewswire • 11-02-2022
Medifast Survey Finds 8 out of 10 U.S. Adults say Practicing Daily "Self-Care Habits" is a Priority
By PRNewswire • 09-07-2023
Medifast Announces Quarterly Dividend
By PRNewswire PRNewswire • 06-15-2023
